Immuto Scientific has been awarded a $2.5 million Phase II SBIR grant from the National Institutes of Health (NIH), the company announced recently. According to a release, the grant will…

Immuto Scientific closed a $2.3 million seed funding round, the company announced recently. Wisconsin Investment Partners (WIP) led the round, with participation from the Wisconsin Alumni Research Foundation (WARF), Great Oaks…